[Is the same tyrosine kinase inhibitor still effective after development of brain metastases? A Case report].

Obertova J, Mego M, Palacka P, Rajec J, Chovanec M, Mardiak J

Open source

DOI
10.14735/amko2013286
Published
2013
Container
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.14735/amko2013286,
  title = {[Is the same tyrosine kinase inhibitor still effective after development of brain metastases? A Case report].},
  author = {Obertova J and Mego M and Palacka P and Rajec J and Chovanec M and Mardiak J},
  year = {2013},
  journal = {Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti},
  doi = {10.14735/amko2013286},
  url = {https://doi.org/10.14735/amko2013286}
}

RIS

TY  - JOUR
TI  - [Is the same tyrosine kinase inhibitor still effective after development of brain metastases? A Case report].
AU  - Obertova J
AU  - Mego M
AU  - Palacka P
AU  - Rajec J
AU  - Chovanec M
AU  - Mardiak J
PY  - 2013
JO  - Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
DO  - 10.14735/amko2013286
UR  - https://doi.org/10.14735/amko2013286
ER  - 

APA

J, O., M, M., P, P., J, R., M, C., & J, M. (2013). [Is the same tyrosine kinase inhibitor still effective after development of brain metastases? A Case report].. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. https://doi.org/10.14735/amko2013286

Source records